153 related articles for article (PubMed ID: 38533530)
1. Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials?
Valaire R; Garden F; Razmovski-Naumovski V
J Cachexia Sarcopenia Muscle; 2024 Mar; ():. PubMed ID: 38533530
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.
Gresham G; Placencio-Hickok VR; Lauzon M; Nguyen T; Kim H; Mehta S; Paski S; Pandol SJ; Osipov A; Gong J; Jamil LH; Nissen N; Lo SK; Hendifar AE
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1959-1968. PubMed ID: 34609081
[TBL] [Abstract][Full Text] [Related]
4. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
[TBL] [Abstract][Full Text] [Related]
5. Exercise for cancer cachexia in adults.
Grande AJ; Silva V; Sawaris Neto L; Teixeira Basmage JP; Peccin MS; Maddocks M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010804. PubMed ID: 33735441
[TBL] [Abstract][Full Text] [Related]
6. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
[TBL] [Abstract][Full Text] [Related]
7. A triple-masked, two-center, randomized parallel clinical trial to assess the superiority of eight weeks of grape seed flour supplementation against placebo for weight loss attenuation during perioperative period in patients with cachexia associated with colorectal cancer: a study protocol.
Malta FAPS; Gonçalves DC
Front Endocrinol (Lausanne); 2023; 14():1146479. PubMed ID: 38313843
[TBL] [Abstract][Full Text] [Related]
8. Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
Vagnildhaug OM; Balstad TR; Ottestad I; Bye A; Greil C; Arends J; Baracos V; Brown LR; Dajani OF; Dolan RD; Fallon M; Fraser E; Grzyb A; Hjermstad MJ; Jakobsen G; Kaasa S; McDonald J; Philips I; Sayers J; Simpson MR; Sousa MS; Skipworth RJE; Laird BJA; Solheim TS;
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):513-535. PubMed ID: 38343065
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia.
Robinson DW; Eisenberg DF; Cella D; Zhao N; de Boer C; DeWitte M
J Support Oncol; 2008; 6(6):283-90. PubMed ID: 18724539
[TBL] [Abstract][Full Text] [Related]
11. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-Related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients with, or without, High Protein Nutritional Support. A Prospective, Randomized Study.
Ziętarska M; Krawczyk-Lipiec J; Kraj L; Zaucha R; Małgorzewicz S
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29019951
[TBL] [Abstract][Full Text] [Related]
13. Adverse events in people taking macrolide antibiotics versus placebo for any indication.
Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650
[TBL] [Abstract][Full Text] [Related]
14. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma.
Mitsunaga S; Kasamatsu E; Machii K
Support Care Cancer; 2020 Nov; 28(11):5271-5279. PubMed ID: 32103356
[TBL] [Abstract][Full Text] [Related]
15. Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia.
Stene GB; Balstad TR; Leer ASM; Bye A; Kaasa S; Fallon M; Laird B; Maddocks M; Solheim TS
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31816924
[TBL] [Abstract][Full Text] [Related]
16. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004080. PubMed ID: 31329285
[TBL] [Abstract][Full Text] [Related]
17. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD004080. PubMed ID: 30353940
[TBL] [Abstract][Full Text] [Related]
18. Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomiting.
Ross DD; Alexander CS
Am Fam Physician; 2001 Sep; 64(5):807-14. PubMed ID: 11563572
[TBL] [Abstract][Full Text] [Related]
19. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Alderman B; Hui D; Mukhopadhyay S; Bouleuc C; Case AA; Amano K; Crawford GB; de Feo G; Sbrana A; Tanco K; To J; Garsed J; Davis M
Support Care Cancer; 2022 Dec; 31(1):39. PubMed ID: 36525085
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Garon EB; Cho BC; Luft A; Alatorre-Alexander J; Geater SL; Kim SW; Ursol G; Hussein M; Lim FL; Yang CT; Araujo LH; Saito H; Reinmuth N; Medic N; Mann H; Shi X; Peters S; Mok T; Johnson M
Lung Cancer; 2023 Dec; 186():107422. PubMed ID: 37992595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
